Market Place
Sourcing Support
Novartis` Coartem Baby Granted WHO Prequalification
24 Apr 2026 //
GLOBENEWSWIRE
Novartis Gets CHMP Nod For Itvisma In SMA
24 Apr 2026 //
GLOBENEWSWIRE
NCCN Honors Initiatives Advancing Leukemia CML Care
23 Apr 2026 //
PR NEWSWIRE
Novartis` Lutathera Radioligand Therapy Faces Generic Rivals
23 Apr 2026 //
ENDPOINTS
Novartis Narrows Anticoagulant`s Focus After Losing To Eliquis
22 Apr 2026 //
FIERCE BIOTECH
Novartis cuts two Programs in Cancer-Related Blood Clots
20 Apr 2026 //
ENDPOINTS
Novartis CEO Vas Narasimhan joins Anthropic board
20 Apr 2026 //
INDPHARMAPOST
NIPER Mohali And Novartis Partner To Enhance R&D Innovation
16 Apr 2026 //
INDPHARMAPOST
Novartis CEO Vas Narasimhan joins Anthropic`s board
16 Apr 2026 //
FIERCE PHARMA
Novartis Pumps Up Heart Disease, Cancer Community Health Plan
10 Apr 2026 //
FIERCE PHARMA
Novartis To Cut 114 More Jobs At New Jersey HQ
10 Apr 2026 //
FIERCE PHARMA
Novartis Expands Global Health Programs For Heart Disease
09 Apr 2026 //
GLOBENEWSWIRE
Biontech To Turn Out The Lights At Singapore Vaccine Facility
02 Apr 2026 //
FIERCE PHARMA
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
Novartis Data In Nejm: Fabhalta Slows Kidney Decline By 49.3%
29 Mar 2026 //
GLOBENEWSWIRE
Novartis to buy based biotech firm Excellergy for up to $2 bn
27 Mar 2026 //
REUTERS
Novartis Sued Over Third-Party Data Sharing From Branded Sites
25 Mar 2026 //
FIERCE PHARMA
Novartis Pledges $480M for China Expansion Following Lilly and AZ
24 Mar 2026 //
BIOSPACE
Novartis Shares Skin Relief Data at AAD 2026
23 Mar 2026 //
GLOBENEWSWIRE
Novartis Pledges Nearly $480M To Bolster China Production, R&D
23 Mar 2026 //
WEIXIN
Novartis to Buy Experimental Breast Cancer Drug in up to $3B
23 Mar 2026 //
REUTERS
Delhi HC Rebukes Patent Office For Delay In Breast Cancer Drug
18 Mar 2026 //
ECONOMICTIMES
Novartis` Cosentyx Gets FDA Approval for Moderate-to-Severe HS
14 Mar 2026 //
GLOBENEWSWIRE
Novartis Shareholders Approve Board Resolutions At AGM 2026
06 Mar 2026 //
GLOBENEWSWIRE
How Jeff Legos Builds Pfizer`s Oncology Future
04 Mar 2026 //
FIERCE BIOTECH
Novartis Completes Acquisition of Avidity Biosciences
27 Feb 2026 //
GLOBENEWSWIRE
Atrium Arises From Avidity Buyout With $270M, Preclinical Assets
27 Feb 2026 //
FIERCE BIOTECH
Novartis Receives Positive CHMP Opinion for Remibrutinib in CSU
27 Feb 2026 //
GLOBENEWSWIRE
Novartis Picks Texas City for 5th U.S. Radiopharm Facility
25 Feb 2026 //
BIOSPACE
Novartis Settles Lawsuit With Estate Of Henrietta Lacks
24 Feb 2026 //
FIERCE PHARMA
Novartis Reveals Rhapsido`s Broader Reach Beyond CSU at AAAAI
23 Feb 2026 //
GLOBENEWSWIRE
Novartis to Exit India unit in $159M deal; Share Surge
21 Feb 2026 //
REUTERS
Novartis` Remibrutinib First to Meet Phase III Endpoint in CIndU
20 Feb 2026 //
GLOBENEWSWIRE
Novartis Finds Natural Partnership In Macrocycle Biotech
20 Feb 2026 //
FIERCE BIOTECH
Novartis Jettisons Ph. 1 Cancer Candidate After 0% Efficacy
19 Feb 2026 //
FIERCE BIOTECH
Trump meets Novartis CEO, says Drugmaker Building 11 US plants
19 Feb 2026 //
REUTERS
Novartis Vanrafia Shows Phase III Data Backing Kidney Function
13 Feb 2026 //
GLOBENEWSWIRE
Niowave, Novartis Ink Actinium-225 Deal for Cancer Therapy
11 Feb 2026 //
PR NEWSWIRE
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
Novartis CEO Pay Soars 30% To $32M In 2025
09 Feb 2026 //
FIERCE PHARMA
Novartis Initiates Construction Of San Diego Biomedical Research
06 Feb 2026 //
GLOBENEWSWIRE
Novartis Cuts 6 Cancer Candidates, Adds 2 to Oncology Strategy
05 Feb 2026 //
BIOSPACE
Novartis: 2023 Growth, 40% Core Margin, Pipeline Wins
04 Feb 2026 //
GLOBENEWSWIRE
Novartis Super Bowl Ad Drafts NFL Stars For Prostate Cancer Push
29 Jan 2026 //
FIERCE PHARMA
Novartis ianalumab receives BTD designation for Sjögren’s disease
16 Jan 2026 //
GLOBENEWSWIRE
Novartis Doesn`t Need GLP-1s in Me-Too World
13 Jan 2026 //
BIOSPACE
Zonsen Peplib Biotech And Novartis Ink Global License Deal
13 Jan 2026 //
PHARMIWEB
JPM26, Day 1: Updates From Lilly, Takeda, Novartis And Sofinnova
12 Jan 2026 //
FIERCE BIOTECH
Novartis Makes $1.5B+ Alzheimer`s Play With China`s Scineuro
12 Jan 2026 //
PR NEWSWIRE
Novartis Charts Next US Investment With New Radiopharma Plant
12 Jan 2026 //
FIERCE PHARMA
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Novartis, US Government Agree To Lower US Drug Prices
19 Dec 2025 //
GLOBENEWSWIRE
Novartis Builds Largest Global R&D Hub In India
18 Dec 2025 //
ECONOMICTIMES
Voyager Jettisons Staff, Novartis Hands Back 2 Programs
18 Dec 2025 //
FIERCE BIOTECH
Novartis Taps Salesforce Agentforce for Engagement Boost
17 Dec 2025 //
BUSINESSWIRE
Novartis Names Vrinda Taneja Director Of People & Organization
14 Dec 2025 //
INDPHARMAPOST
Novartis Ground on Flagship Manufacturing Hub in North Carolina
12 Dec 2025 //
GLOBENEWSWIRE
Novartis Pens $1.7 B Immuno-Dermatology Pact with AI Biotech
10 Dec 2025 //
GLOBENEWSWIRE
Novartis` Kisqali Keeps 1 in 4 Patients Progression-Free
09 Dec 2025 //
GLOBENEWSWIRE
Novartis` Ianalumab Sustains ITP Control for 4 Months
09 Dec 2025 //
GLOBENEWSWIRE
